trending Market Intelligence /marketintelligence/en/news-insights/trending/BVzkYPt8As1Oos9h0h0iYw2 content esgSubNav
In This List

Axovant Sciences to raise $40M via common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Axovant Sciences to raise $40M via common stock offering

Axovant Sciences Ltd. is planning to raise $40 million in gross proceeds through an underwritten offering of common shares.

The London-based developer of neurological and psychiatric treatments plans to issue 26,666,667 common shares for $1.50 per share as part of the offering.

Axovant Sciences also granted underwriters an option to buy up to an additional 4 million common shares. The offering is expected to close March 18.

Jefferies LLC and Guggenheim Securities LLC are acting as underwriters for the offering.